Evidence map›Paper›PMID 39622875›Full record

ArticleScientific reports2024

Examining the effects of biofield therapy through simultaneous assessment of electrophysiological and cellular outcomes.

Lorenzo Cohen, Arnaud Delorme, Andrew Cusimano, Sharmistha Chakraborty, Phuong Nguyen, Defeng Deng, Shafaqmuhammad Iqbal, Monica Nelson, Daoyan Wei, Chris Fields and 1 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Lorenzo Cohen *The University of Texas MD Anderson Cancer Center, Houston, TX, USA. lcohen@mdanderson.org.
Arnaud Delorme *Institute of Noetic Sciences, Novato, CA, USA.
Andrew CusimanoThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Sharmistha ChakrabortyThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Phuong NguyenThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Defeng DengThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shafaqmuhammad IqbalThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Monica NelsonThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Daoyan WeiThe University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Chris Fields, 11160, Caunes Minervois, France.
Peiying Yang *The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Funding

Emerald Gate Charitable Trust RCTS LS2022-00061373-LK
6 · The paper itself

Abstract

In this case study, a self-described biofield therapy (BT) practitioner (participant) took part in multiple (n = 60) treatment and control (non-treatment) sessions under double-blind conditions. During the treatment phases, the participant provided BT treatment at a distance of about 12 inches from the cells, alternating with rest phases where no such efforts were made. Human pancreatic cancer cell activity was assessed using three markers - cytoskeleton changes (tubulin and β-actin) and Ca

Indexed as

ElectroencephalographyPancreatic NeoplasmsCalciumDouble-Blind MethodElectrophysiological PhenomenaFemaleHeart RateHumansMaleCalciumBiofield Therapy (BT)Double-blindElectroencephalogram (EEG)Granger CausalityHeart Rate Variability (HRV)Pancreatic Cancer cells

Identifiers

PMID39622875
PMCPMC11612308

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.